Financhill
Sell
9

PBDIF Quote, Financials, Valuation and Earnings

Last price:
$0.31
Seasonality move :
0%
Day range:
$0.31 - $0.31
52-week range:
$0.31 - $0.31
Dividend yield:
2.55%
P/E ratio:
14.60x
P/S ratio:
2.38x
P/B ratio:
0.91x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$3B
Revenue:
$1.3B
EPS (TTM):
$0.02

Analysts' Opinion

  • Consensus Rating
    PT Bank Danamon Indonesia Tbk has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, PT Bank Danamon Indonesia Tbk has an estimated downside of -- from its current price of $0.31.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $0.31.

Fair Value

  • According to the consensus of 0 analysts, PT Bank Danamon Indonesia Tbk has -- downside to fair value with a price target of -- per share.

PBDIF vs. S&P 500

  • Over the past 5 trading days, PT Bank Danamon Indonesia Tbk has underperformed the S&P 500 by -1.77% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • PT Bank Danamon Indonesia Tbk does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • PT Bank Danamon Indonesia Tbk has grown year-over-year revenues for 6 quarters straight. In the most recent quarter PT Bank Danamon Indonesia Tbk reported revenues of $319.2M.

Earnings Growth

  • PT Bank Danamon Indonesia Tbk earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter PT Bank Danamon Indonesia Tbk reported earnings per share of $0.01.
Enterprise value:
3.4B
EV / Invested capital:
0.74x
Price / LTM sales:
2.38x
EV / EBIT:
5.05x
EV / Revenue:
2.71x
PEG ratio (5yr expected):
1.80x
EV / Free cash flow:
9.51x
Price / Operating cash flow:
8.36x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.44%
Net Income Margin (TTM):
16.32%
Return On Equity:
6.51%
Return On Invested Capital:
4.8%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $1.2B $1.2B $1.3B $312.4M $319.2M
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS $0.02 $0.02 $0.02 $0.01 $0.01
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $2B $1.5B $1.6B $1.5B $1.4B
Total Assets $13.2B $13B $12.5B $13.5B $15.9B
Current Liabilities $62.1M $47.6M $52.5M $78.1M $70.3M
Total Liabilities $10.2B $9.9B $9.4B $10.4B $12.5B
Total Equity $2.9B $3.1B $3.1B $3.2B $3.4B
Total Debt $1.4B $836.3M $661.1M $945.7M $1.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$311.1M -$506.5M $422.1M $28.3M $347M
Cash From Investing $708.9M $317.1M -$1B $88.6M -$386.6M
Cash From Financing -$198.3M $203.5M $407.7M $20M $32.2M
Free Cash Flow -$332M -$543.4M $362.4M $18.5M $336.4M
PBDIF
Sector
Market Cap
$3B
$700.3M
Price % of 52-Week High
100%
88.31%
Dividend Yield
2.55%
2.2%
Shareholder Yield
--
3.87%
1-Year Price Total Return
--
7.75%
Beta (5-Year)
--
0.737
Dividend yield:
2.55%
Annualized payout:
$0.01
Payout ratio:
39.78%
Growth streak:
2 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $0.31
200-day SMA
Sell
Level $0.31
Bollinger Bands (100)
Sell
Level 0.31 - 0.31
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $0.31
Relative Strength Index (RSI14)
Sell
Level 0.00
ADX Line
Neutral
Level
Williams %R
Buy
Level 0
50-day SMA
Sell
Level $0.31
MACD (12, 26)
Sell
Level 0.00
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Neutral
Level --

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.7527)
Sell
CA Score (Annual)
Level (-1.4636)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (5)
Sell
Ohlson Score
Level (0.9829)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

PT Bank Danamon Indonesia Tbk is an Indonesia-based company that is principally engaged in providing banking services. The company's core business segments consist of the retail business segment, which includes micro banking, retail banking, a credit card business, insurance, consumer financing, and syariah banking, and the wholesale business segment, which provides commercial and corporate customers with products such as cash management, trade finance, financial supply chain, loans, and foreign exchange transactions. It generates maximum revenue from the retail business segment.

Stock Forecast FAQ

In the current month, PBDIF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PBDIF average analyst price target in the past 3 months is --.

  • Where Will PT Bank Danamon Indonesia Tbk Stock Be In 1 Year?

    According to analysts, the consensus estimate is that PT Bank Danamon Indonesia Tbk share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About PT Bank Danamon Indonesia Tbk?

    Analysts are divided on their view about PT Bank Danamon Indonesia Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Bank Danamon Indonesia Tbk is a Sell and believe this share price will rise from its current level to --.

  • What Is PT Bank Danamon Indonesia Tbk's Price Target?

    The price target for PT Bank Danamon Indonesia Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PBDIF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for PT Bank Danamon Indonesia Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of PBDIF?

    You can purchase shares of PT Bank Danamon Indonesia Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Bank Danamon Indonesia Tbk shares.

  • What Is The PT Bank Danamon Indonesia Tbk Share Price Today?

    PT Bank Danamon Indonesia Tbk was last trading at $0.31 per share. This represents the most recent stock quote for PT Bank Danamon Indonesia Tbk. Yesterday, PT Bank Danamon Indonesia Tbk closed at $0.31 per share.

  • How To Buy PT Bank Danamon Indonesia Tbk Stock Online?

    In order to purchase PT Bank Danamon Indonesia Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is up 10.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock